Press Release:Sep 28, 2023
Harbinger Health Raises $140 Million in Series B Funding to Accelerate Advancement of its Screening Platform for Early-Stage Cancers
read more.news & perspectives
Press Release:Sep 6, 2023
Harbinger Health Expands Industry-Leading Executive Team
read more.Press Release:Jul 26, 2023
Harbinger Health Announces Data Demonstrating Its Ability to Detect Early-Stage Multi-Cancer at the AACC Annual Scientific Meeting 2023
read more.Press Release:May 25, 2023
Harbinger Health Announces Results Demonstrating High-Sensitivity of Early Stage Multi-Cancer Detection Platform at ASCO Annual Meeting 2023
read more.Press Release:May 23, 2023
Harbinger Health Appoints May Orfali, M.D. as Chief Medical Officer
read more.Press Release:Feb 13, 2023
Harbinger Health Appoints Vincent Lozada as Chief Financial Officer
read more.Press Release:Jun 29, 2022
Harbinger Health and Sarah Cannon Research Institute Launch Clinical Study to Validate and Advance Development of Harbinger’s Novel Early Cancer Detection Platform
read more.